Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 52,890 shares at $29.14 ($1.6M) on 2021-08-16, disclosed to the SEC on 2021-08-17.
Open-market sale of $1.6M YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.01 | 1,110 | $34K | 2.2% |
| 2 | $29.14 | 4,000 | $117K | 7.5% |
| 3 | $29.33 | 22,111 | $649K | 41.8% |
| 4 | $29.33 | 22,111 | $649K | 41.8% |
| 5 | $28.96 | 1,779 | $52K | 3.3% |
| 6 | $28.96 | 1,779 |
| $52K |
| 3.3% |
| Total | $29.33 avg | 52,890 | $1.6M | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |